Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.

$218.2B

Market Cap • 4/3/2025

1970

(55 years)

Founded

1949

(76 years ago)

IPO

NYSE

Listing Exchange

Flag of US

Rahway

Headquarters • New Jersey

S&P500 Participant

Index Composite • 2025